Sagax AB Series B
AB Sagax (publ), a property company, owns and manages a property portfolio in Sweden, Finland, France, Benelux, Spain, Germany, and other European countries. The company invests in commercial properties primarily in the warehouse and light industrial segments. It also engages in the financial administration and asset management activities. The company was incorporated in 1995 and is headquartered… Read more
Sagax AB Series B (0QDX) - Total Liabilities
Latest total liabilities as of September 2021: Skr30.08 Billion SEK
Based on the latest financial reports, Sagax AB Series B (0QDX) has total liabilities worth Skr30.08 Billion SEK as of September 2021.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Sagax AB Series B - Total Liabilities Trend (2016–2020)
This chart illustrates how Sagax AB Series B's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Sagax AB Series B Competitors by Total Liabilities
The table below lists competitors of Sagax AB Series B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
China Minmetals Rare Earth Co Ltd
SHE:000831
|
China | CN¥817.69 Million |
|
Essent Group Ltd
NYSE:ESNT
|
USA | $1.61 Billion |
|
GPT Group
PINK:GPTGF
|
USA | $6.30 Billion |
|
Rightmove plc
PINK:RTMVF
|
USA | $43.22 Million |
|
China Merchants Energy Shipping Co Ltd
SHG:601872
|
China | CN¥36.68 Billion |
|
Shanghai Fudan Microelectronics Group Co Ltd
SHG:688385
|
China | CN¥2.48 Billion |
|
Cogent Biosciences Inc
NASDAQ:COGT
|
USA | $301.24 Million |
Liability Composition Analysis (2016–2020)
This chart breaks down Sagax AB Series B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.19 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.53 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sagax AB Series B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sagax AB Series B (2016–2020)
The table below shows the annual total liabilities of Sagax AB Series B from 2016 to 2020.
| Year | Total Liabilities | Change |
|---|---|---|
| 2020-12-31 | Skr24.17 Billion | +15.66% |
| 2019-12-31 | Skr20.90 Billion | +14.35% |
| 2018-12-31 | Skr18.27 Billion | +15.05% |
| 2017-12-31 | Skr15.88 Billion | +10.34% |
| 2016-12-31 | Skr14.39 Billion | -- |